Agomelatine improves symptoms of generalised anxiety disorder

Evidence-Based Mental Health

Volumn 12, Issue 2, 2009, Pages 54-

  Baldwin, David S ^a   Lopes, Antonio T ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67449152189     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebmh.12.2.54     Document Type: Note

References (3)

1. Baldwin DS. Room for improvement in the pharmacological treatment of anxiety disorders. Curr Pharm Design 2008; 14:3482-91.
2. Stahl S. Novel mechanism of antidepressant action: norepinephrine and dopamine disinhibition (NDDI) plus melatonergic agonism. Int J Neuropsychopharmacol 2007; 10:575-8.
3. Naukkarinen H, Raassina R, Penttinen J, et al. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dosefinding study. Eur Neuropsychopharmacol 2005; 15: 617-23.